Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments

Press/Media

Period	24 Oct 2023

Media coverage

Title	Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments
Media name/outlet	UK Biotech Database
Country/Territory	Switzerland
Date	24/10/23
URL	ct.moreover.com/?a=52148266028&p=1gw&v=1&x=Wyl7r5FLghT3xJ8gZAvlAQ
Persons	Mirna Chehade